US Patent 9,624,549 has been issued!
“Stable gene targets in breast cancer and use thereof for optimizing therapy. ” Peter K Rogan and Joan Knoll. (link)
This technology is the basis of biochemically inspired chemotherapy prediction by machine learning (http://chemotherapy.cytognomix.com).
- April 18, 2017. US Patent 9,624,549 issued about chemotherapy target identification
- April 8, 2017. Presentation about chemotherapy outcome prediction
- March 31, 2017. New preprint on increased accuracy in radiation biodosimetry
- February 27, 2017. CytoGnomix finalizes contract with Government of Canada